We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
2351
DELISTED
Chimerix, Inc.
CMRX
| $98K | ﹤0.01% |
+10,170
| New | +$93.3K |
|
2352
WidePoint Corp
WYY
$100M
| $96K | ﹤0.01% |
+10,484
| New | +$124K |
|
2353
CALL
Caterpillar
CAT
$383B
| $93K | ﹤0.01% |
+400
| New | +$82.8K |
|
|
2354
PUT
Thermo Fisher Scientific
TMO
$215B
| $91K | ﹤0.01% |
+200
| New | +$95.5K |
|
2355
ReWalk Robotics
LFWD
$19.5M
| $91K | ﹤0.01% |
+448
| New | +$103K |
|
|
IVC
2356
DELISTED
Invacare Corporation
IVC
| $88K | ﹤0.01% |
10,935
-13,044
| -54% | -$122K |
|
|
USDP
2357
DELISTED
USD PARTNERS LP
USDP
| $87K | ﹤0.01% |
+14,929
| New | +$74.3K |
|
2358
Flotek Industries
FTK
$852M
| $86K | ﹤0.01% |
+8,492
| New | +$106K |
|
|
RGLS
2359
DELISTED
Regulus Therapeutics
RGLS
| $81K | ﹤0.01% |
+5,169
| New | +$76.5K |
|
2360
W&T Offshore
WTI
$470M
| $80K | ﹤0.01% |
+22,301
| New | +$69.3K |
|
|
TWAV
2361
TaoWeave Inc
TWAV
$4.35M
| $79K | ﹤0.01% |
+26
| New | +$70.6K |
|
|
WPG
2362
DELISTED
Washington Prime Group Inc.
WPG
| $79K | ﹤0.01% |
+35,640
| New | +$260K |
|
|
SVM
2363
Silvercorp Metals
SVM
$2.09B
| $78K | ﹤0.01% |
+15,844
| New | +$92.9K |
|
2364
GSI Technology
GSIT
$213M
| $77K | ﹤0.01% |
+11,493
| New | +$86.1K |
|
2365
CALL
Ford
F
$59.7B
| $74K | ﹤0.01% |
+6,000
| New | +$68.7K |
|
2366
TETRA Technologies
TTI
$1.06B
| $72K | ﹤0.01% |
+30,048
| New | +$64.7K |
|
2367
CALL
Comcast
CMCSA
$85.8B
| $71K | ﹤0.01% |
+1,300
| New | +$68.7K |
|
2368
Kamada
KMDA
$398M
| $71K | ﹤0.01% |
11,594
-54,578
| -82% | -$361K |
|
2369
cbdMD
YCBD
$5.27M
| $68K | ﹤0.01% |
+46
| New | +$66.9K |
|
2370
Vaalco Energy
EGY
$538M
| $66K | ﹤0.01% |
+29,266
| New | +$77.1K |
|
2371
PUT
AbbVie
ABBV
$468B
| $65K | ﹤0.01% |
+600
| New | +$64.2K |
|
2372
Evogene
EVGN
$6M
| $65K | ﹤0.01% |
+1,287
| New | +$79.6K |
|
2373
PUT
Freeport-McMoran
FCX
$89B
| $63K | ﹤0.01% |
+1,900
| New | +$61.6K |
|
2374
Solitario Resources
XPL
$66.8M
| $63K | ﹤0.01% |
+75,748
| New | +$64.2K |
|
2375
Expro Ltd
XPRO
$1.81B
| $63K | ﹤0.01% |
2,949
-21,888
| -88% | -$476K |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.